Literature DB >> 1803179

Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

U Ringborg1, B Lagerlöf, M Broberg, E Månsson-Brahme, A Platz, M Thörn.   

Abstract

The incidence of cutaneous malignant melanoma has increased more than the incidence of any other malignant tumour disease in Sweden the last three decades. Parallel to the almost 6% annual increase in incidence there has been a 3% annual increase in mortality. The knowledge of significant risk factors for melanoma (intermittent sun exposure and phenotypic traits related to skin pigmentation and propensity for dysplastic nevi) as well as the relationship between thin tumours and a good prognosis has been used to develop strategies for primary and secondary prevention. In this paper the Swedish programs for education of physicians, nurses and the general population are presented. A nationwide program for the identification and follow-up of individuals with dysplastic nevus syndrome has been initiated. The effects of the programs are followed by population-based melanoma registries.

Entities:  

Mesh:

Year:  1991        PMID: 1803179     DOI: 10.1007/BF02987178

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  31 in total

1.  Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.

Authors:  M Thörn; R Bergström; H O Adami; U Ringborg
Journal:  Am J Epidemiol       Date:  1990-12       Impact factor: 4.897

2.  Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions?

Authors:  R Philipp; A Hastings; J Briggs; J Sizer
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

3.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

4.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

Authors:  L J van 't Veer; B M Burgering; R Versteeg; A J Boot; D J Ruiter; S Osanto; P I Schrier; J L Bos
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

6.  Trends in survival from malignant melanoma: remarkable improvement in 23 years.

Authors:  M Thörn; H O Adami; R Bergström; U Ringborg; U B Krusemo
Journal:  J Natl Cancer Inst       Date:  1989-04-19       Impact factor: 13.506

7.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

8.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

9.  Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study.

Authors:  J M Elwood; R P Gallagher; G B Hill; J C Pearson
Journal:  Int J Cancer       Date:  1985-04-15       Impact factor: 7.396

10.  Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits.

Authors:  C D Holman; B K Armstrong; P J Heenan
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

View more
  1 in total

1.  Feasibility of targeted early detection for melanoma: a population-based screening study.

Authors:  J Melia; C Harland; S Moss; J R Eiser; L Pendry
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.